Eli Lilly makes a new push into vaccines – here’s what to know
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
Eli Lilly weight loss drug retatrutide clears obesity trial
Eli Lilly on Thursday said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering…
Biogen Alzheimer’s drug moves to late stage trial
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for…
Novo Nordisk releases new high-dose Wegovy data
A Wegovy injection pen shown in Waterbury, Vermont, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images…
Novo Nordisk faces Ozempic generics in Canada
Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
How Barrière aims to disrupt the supplement industry
The supplement industry has seen booming demand over the past few years as consumers increasingly focus on health…
CVS Health (CVS) earnings Q1 2026
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24,…
Pfizer (PFE) earnings Q1 2026
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…
UnitedHealth, Cigna, Humana earnings show insurers are recovering
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to…
FDA proposes excluding Novo, Lilly GLP-1s from compounding list
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…
20,000 people taking drug, Ricks says
More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on…
Eli Lilly (LLY) earnings Q1 2026
Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales…